P&K Skin Research Center Co. Ltd (347740) - Total Assets
Based on the latest financial reports, P&K Skin Research Center Co. Ltd (347740) holds total assets worth ₩85.87 Billion KRW (≈ $58.20 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See P&K Skin Research Center Co. Ltd (347740) shareholders funds for net asset value and shareholders' equity analysis.
P&K Skin Research Center Co. Ltd - Total Assets Trend (2018–2024)
This chart illustrates how P&K Skin Research Center Co. Ltd's total assets have evolved over time, based on quarterly financial data.
P&K Skin Research Center Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
P&K Skin Research Center Co. Ltd's total assets of ₩85.87 Billion consist of 58.7% current assets and 41.3% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩6.46 Billion | 7.9% |
| Accounts Receivable | ₩1.37 Billion | 1.7% |
| Inventory | ₩0.00 | 0.0% |
| Property, Plant & Equipment | ₩3.64 Billion | 4.4% |
| Intangible Assets | ₩198.35 Million | 0.2% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2018–2024)
This chart illustrates how P&K Skin Research Center Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 347740 stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: P&K Skin Research Center Co. Ltd's current assets represent 58.7% of total assets in 2024, a decrease from 71.0% in 2018.
- Cash Position: Cash and equivalents constituted 7.9% of total assets in 2024, up from 0.0% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is cash and equivalents at 7.9% of total assets.
P&K Skin Research Center Co. Ltd Competitors by Total Assets
Key competitors of P&K Skin Research Center Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Genetic Signatures Ltd
AU:GSS
|
Australia | AU$54.63 Million |
|
Leveljump Healthcare Corp
V:JUMP
|
Canada | CA$21.84 Million |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
P&K Skin Research Center Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 13.91 | 12.46 | 14.38 |
| Quick Ratio | 13.91 | 12.46 | 14.38 |
| Cash Ratio | 0.00 | 1.86 | 0.00 |
| Working Capital | ₩44.27 Billion | ₩47.95 Billion | ₩47.69 Billion |
P&K Skin Research Center Co. Ltd - Advanced Valuation Insights
This section examines the relationship between P&K Skin Research Center Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.85 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 6.0% |
| Total Assets | ₩82.04 Billion |
| Market Capitalization | $48.83 Million USD |
Valuation Analysis
Below Book Valuation: The market values P&K Skin Research Center Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: P&K Skin Research Center Co. Ltd's assets grew by 6.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for P&K Skin Research Center Co. Ltd (2018–2024)
The table below shows the annual total assets of P&K Skin Research Center Co. Ltd from 2018 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩82.04 Billion ≈ $55.60 Million |
+5.98% |
| 2023-12-31 | ₩77.41 Billion ≈ $52.46 Million |
+3.85% |
| 2022-12-31 | ₩74.54 Billion ≈ $50.51 Million |
+11.10% |
| 2021-12-31 | ₩67.09 Billion ≈ $45.47 Million |
+12.02% |
| 2020-12-31 | ₩59.89 Billion ≈ $40.59 Million |
+114.14% |
| 2019-12-31 | ₩27.97 Billion ≈ $18.95 Million |
+58.55% |
| 2018-12-31 | ₩17.64 Billion ≈ $11.95 Million |
-- |
About P&K Skin Research Center Co. Ltd
P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for new cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vi… Read more